Mejares, Rhea Mae .
HRN: 22-41-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
CEFUROXIME 750MG (VIAL)
02/14/2026
02/20/2026
IV
375mg
Q8H
UTI; T/C Dengue Shock Syndrome
Checking Initial Appropriateness
02/17/2026
MUPIROCIN 2%, 15G (TUBE)
02/17/2026
02/24/2026
TOPICAL
As Much Needed
BID
Prophylaxis For Skin Infection
Checking Initial Appropriateness